1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Transdermal Drug Delivery System Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Transdermal Drug Delivery System Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Transdermal Drug Delivery System Market Regional Analysis
6.2 Asia Pacific Transdermal Drug Delivery System Market Revenue 2020-2030 (US$ Million)
6.3 Asia Pacific Transdermal Drug Delivery System Market Forecast Analysis
7. Asia Pacific Transdermal Drug Delivery System Market Analysis – by Type
7.1 Transdermal Patches
- 7.1.1 Overview
- 7.1.2 Transdermal Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Transdermal Gel
- 7.2.1 Overview
- 7.2.2 Transdermal Gel: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Transdermal Sprays
- 7.3.1 Overview
- 7.3.2 Transdermal Sprays: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Asia Pacific Transdermal Drug Delivery System Market Analysis – by Application
8.1 Cardiovascular Diseases
- 8.1.1 Overview
- 8.1.2 Cardiovascular Diseases: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Central Nervous System Disorders
- 8.2.1 Overview
- 8.2.2 Central Nervous System Disorders: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Pain Management
- 8.3.1 Overview
- 8.3.2 Pain Management: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Hormonal Applications
- 8.4.1 Overview
- 8.4.2 Hormonal Applications: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.5 Other Applications
- 8.5.1 Overview
- 8.5.2 Other Applications: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Asia Pacific Transdermal Drug Delivery System Market Analysis – by Distribution Channel
9.1 Hospitals Pharmacies
- 9.1.1 Overview
- 9.1.2 Hospitals Pharmacies: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Retail Pharmacies
- 9.2.1 Overview
- 9.2.2 Retail Pharmacies: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Online Pharmacies
- 9.3.1 Overview
- 9.3.2 Online Pharmacies: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Asia Pacific Transdermal Drug Delivery System Market – Asia-Pacific Analysis
10.1 Overview
10.2 Asia-Pacific
- 10.2.1 Asia Pacific Transdermal Drug Delivery System Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.2.1.1 Asia Pacific Transdermal Drug Delivery System Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 China:
Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 China: Asia Pacific Transdermal Drug Delivery System Market Breakdown, by Type
- 10.2.1.1.2 China: Asia Pacific Transdermal Drug Delivery System Market Breakdown, by Application
- 10.2.1.1.3 China: Asia Pacific Transdermal Drug Delivery System Market Breakdown, by Distribution Channel
- 10.2.1.2 India:
Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 India: Asia Pacific Transdermal Drug Delivery System Market Breakdown, by Type
- 10.2.1.2.2 India: Asia Pacific Transdermal Drug Delivery System Market Breakdown, by Application
- 10.2.1.2.3 India: Asia Pacific Transdermal Drug Delivery System Market Breakdown, by Distribution Channel
- 10.2.1.3 Japan:
Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 Japan: Asia Pacific Transdermal Drug Delivery System Market Breakdown, by Type
- 10.2.1.3.2 Japan: Asia Pacific Transdermal Drug Delivery System Market Breakdown, by Application
- 10.2.1.3.3 Japan: Asia Pacific Transdermal Drug Delivery System Market Breakdown, by Distribution Channel
- 10.2.1.4 Australia:
Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.4.1 Australia: Asia Pacific Transdermal Drug Delivery System Market Breakdown, by Type
- 10.2.1.4.2 Australia: Asia Pacific Transdermal Drug Delivery System Market Breakdown, by Application
- 10.2.1.4.3 Australia: Asia Pacific Transdermal Drug Delivery System Market Breakdown, by Distribution Channel
- 10.2.1.5 Rest of Asia-Pacific :
Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Transdermal Drug Delivery System Market Breakdown, by Type
- 10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Transdermal Drug Delivery System Market Breakdown, by Application
- 10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Transdermal Drug Delivery System Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Boehringer Ingelheim International GmbH
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 GSK Plc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Hisamitsu Pharmaceutical Co Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Johnson & Johnson
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Luye Pharma Group Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Novartis AG
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Viatris Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For Asia Pacific Transdermal Drug Delivery System Market
